Recent Marijuana Use and Associations With Exhaled Nitric Oxide and Pulmonary Function in Adults in the United States

Chest
Stefania I PapatheodorouMurray A Mittleman

Abstract

The medical and recreational use of marijuana is now legal in some parts of the United States; the health effects are unknown. We aimed to evaluate associations between recent marijuana use and exhaled nitric oxide (eNO) and pulmonary function. We performed a cross-sectional study of 10,327 US adults participating in the National Health and Nutrition Examination Survey in the years 2007 to 2012. We examined associations between marijuana use and eNO, FEV1, FVC, the FEV1/FVC ratio, and forced expiratory flow (midexpiratory phase) (FEF25%-75%) by weighted linear regression. In the study population, there were 4,797 never users, 4,084 past marijuana users, 555 participants who used marijuana 5 to 30 days before the examination, and 891 participants who used marijuana 0 to 4 days before the examination. Current marijuana use in the past 4 days was associated with 13% lower eNO (95% CI, -18% to 8%). FVC was higher in past users (75 mL; 95% CI, 38-112) and current users in the past 5 to 30 days (159 mL; 95% CI, 80-237) and in users within 0 to 4 days of the examination (204 mL; 95% CI, 139-270) compared with never users. All associations remained unchanged and statistically significant in sensitivity analyses excluding current and pa...Continue Reading

References

Nov 11, 1991·Pharmacology, Biochemistry, and Behavior·M P ShermanD P Tashkin
Mar 1, 1991·International Journal of Epidemiology·D L SherrillM D Lebowitz
Dec 12, 1987·British Medical Journal·J W BloomM D Lebowitz
Nov 1, 1980·Chest·D P TashkinB J Shapiro
Feb 1, 1994·American Journal of Respiratory and Critical Care Medicine·B GastonJ S Stamler
Aug 1, 1995·American Journal of Respiratory and Critical Care Medicine·S A KharitonovP J Barnes
Mar 1, 1994·The European Respiratory Journal·J SchillingS Geroulanos
Jan 1, 1997·American Journal of Respiratory and Critical Care Medicine·D P TashkinA H Coulson
Feb 24, 2001·Addiction·D R TaylorM R Sears
Jun 13, 2001·Circulation·M A MittlemanJ E Muller
Oct 6, 2001·American Journal of Respiratory and Critical Care Medicine·D H YatesP S Thomas
Jul 4, 2002·Clinical Science·M HögmanH Hedenström
Nov 5, 2002·Journal of Clinical Pharmacology·Stephen Sidney
Nov 5, 2002·Journal of Clinical Pharmacology·Donald P TashkinMichael D Roth
Mar 19, 2003·Archives of Environmental Health·Mauro ManiscalcoMatteo Sofia
Mar 26, 2003·Experimental Lung Research·Jeffrey C HoytPeter J Barnes
Jul 23, 2004·Physiological Reviews·Fabio L M RicciardoloGert Folkerts
Feb 8, 2005·Journal of General Internal Medicine·Brent A MooreAlan J Budney
Apr 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN European Respiratory Society
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Apr 6, 2006·Circulation·Ulrich Förstermann, Thomas Münzel
Aug 9, 2006·The American Journal of Cardiology·Nicolas RodondiUNKNOWN Coronary Artery Risk Development in Young Adults (CARDIA) Study
Sep 29, 2006·International Journal of Cardiology·Arash Aryana, Mark A Williams
Feb 14, 2007·Archives of Internal Medicine·Jeanette M TetraultDavid A Fiellin
Aug 2, 2007·Thorax·Sarah AldingtonRichard Beasley
Apr 11, 2008·The Journal of Clinical Hypertension·Ka BianFerid Murad
Aug 15, 2009·The European Respiratory Journal·R J HancoxM R Sears
Oct 20, 2009·Lancet·Wayne Hall, Louisa Degenhardt
Jan 2, 2010·The European Respiratory Journal·D P Tashkin
May 22, 2010·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Rachel NadifIsabelle Pin
Sep 28, 2010·European Journal of Pharmacology·Noboru Toda, Hiroshi Toda
Aug 27, 2011·American Journal of Epidemiology·Yann Le Strat, Bernard Le Foll
Jan 12, 2012·JAMA : the Journal of the American Medical Association·Mark J PletcherStefan Kertesz
Jun 23, 2012·Cardiology·Arlene Bradley LevineT Barry Levine
May 21, 2013·The American Journal of Medicine·Elizabeth A PennerMurray A Mittleman
May 31, 2013·The New England Journal of Medicine·Jonathan N Adler, James A Colbert
Sep 4, 2013·Allergy and Asthma Proceedings·Jeng-Yuan HsuMing-Chih Chou
Nov 30, 2013·Journal of Interpersonal Violence·Christopher P Salas-WrightBrandy R Maynard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.